CN103694290A - Preparation method of 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose - Google Patents

Preparation method of 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose Download PDF

Info

Publication number
CN103694290A
CN103694290A CN201310671212.8A CN201310671212A CN103694290A CN 103694290 A CN103694290 A CN 103694290A CN 201310671212 A CN201310671212 A CN 201310671212A CN 103694290 A CN103694290 A CN 103694290A
Authority
CN
China
Prior art keywords
lactosi
semi
preparation
benzyl
benzothiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310671212.8A
Other languages
Chinese (zh)
Other versions
CN103694290B (en
Inventor
孟庆文
孔令华
张恩选
赵海峰
张雷
索晨苏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Carbotang Biotech Co ltd
Original Assignee
CARBOTANG BIOTECH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CARBOTANG BIOTECH Co Ltd filed Critical CARBOTANG BIOTECH Co Ltd
Priority to CN201310671212.8A priority Critical patent/CN103694290B/en
Publication of CN103694290A publication Critical patent/CN103694290A/en
Application granted granted Critical
Publication of CN103694290B publication Critical patent/CN103694290B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the field of saccharide compounds, particularly a method for preparing 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose. The method comprises the following steps: preparing benzothiazolyl thioacetyl galactose from galactose under the actions of acetic anhydride and a catalyst 2-mercaptobenzothiazole; preparing benzothiazolyl thiotetrabenzyl galactose from the benzothiazolyl thioacetyl galactose under the actions of potassium hydroxide and benzyl chloride; and preparing the 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose from the benzothiazolyl thiotetrabenzyl galactose under the action of N-bromosuccinimide. The method synthesizes the 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose by a three-step reaction process, and effectively enhances the purity and yield of the product; and the method is simple to operate and accessible in raw materials, and saves the operating cost and materials.

Description

The preparation method of 2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose
 
technical field
The present invention relates to sugar compounds field, be specifically related to a kind of 2,3,4, the preparation method of 6-tetra--oxygen-benzyl-D-galactopyranose.
background technology
2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose, claims again 2,3,4,6-, tetra--O-benzyl-D-galactopyranoside, English name: 2,3,4,6-Tetra-O-benzyl-D-galactose, No. CAS: 53081-25-7, molecular formula: C34H36O6.
In the prior art, generally adopt semi-lactosi and Methanol for semi-lactosi first glycosides, then by semi-lactosi first glycosides, prepare tetrabenzyl semi-lactosi, then use triphenyl Tetrafluoroboric acid carbon demethylating.As Mild and Efficient Chemoselective Deprotection of Anomeric O-Methyl Glycosides with Trityl Tetrafluoroborate, Journal of Organic Chemistry, 2008, vol. 73, # 15 p. 5993 – 5995, aforesaid method catalyzer triphenyl Tetrafluoroboric acid carbon ratio is more expensive, cost is too high, or adopt semi-lactosi to carry out acetylize, then prepare p-methylphenyl thioacetyl semi-lactosi, through benzyl, N-bromo-succinimide is sloughed toluene-ω-thiol, thereby preparation 2, 3, 4, 6-tetra--oxygen-benzyl-D-pyrans (type) semi-lactosi, as Synthetic Iminosugar Derivatives as New Potential Immunosuppressive Agents, Journal of Medicinal Chemistry, 2005, vol. 48, # 11 p. 3688 – 3691, in this method, use toxicity more intense, the toluene-ω-thiol that smell is larger.
summary of the invention
In order to solve in above prior art 2,3,4, the cost compare existing in the preparation of 6-tetra--oxygen-benzyl-D-pyrans (type) semi-lactosi is high, the present situation that yield is lower, the invention provides and a kind ofly adopt three-step reaction, simple to operate, raw material is easy to get 2,3, the preparation method of 4,6-, tetra--oxygen-benzyl-D-galactopyranose.
The present invention is achieved by the following measures:
The preparation method of 2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose, comprises the following steps:
A) room temperature adds aceticanhydride and catalyzer, 10-15 ℃ minute 8 batches add semi-lactosi, after having reacted, add 2-mercaptobenzothiazole, be heated to 50-60 ℃; Through aftertreatment, obtain benzothiazolyl thioacetyl semi-lactosi.
B) potassium hydroxide and benzothiazolyl thioacetyl semi-lactosi are added to and in Benzyl Chloride, are heated to back flow reaction and complete, reacted rear cooling, through aftertreatment, obtain benzothiazolyl sulfo-tetrabenzyl semi-lactosi.
C) benzothiazolyl sulfo-tetrabenzyl semi-lactosi is added in acetone and is dissolved, add water, stir in room temperature and add N-bromo-succinimide, stir 0.5 hour, reacted through aftertreatment and obtained 2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose.
Described method, described aceticanhydride: catalyzer: semi-lactosi: the mol ratio of 2-mercaptobenzothiazole is 5.5:2:1:1.1.
Described method, benzothiazolyl thioacetyl semi-lactosi: Benzyl Chloride: the mol ratio of potassium hydroxide is 1:10-15: 4-8.
Described method, the mol ratio of benzothiazolyl sulfo-tetrabenzyl semi-lactosi and N-bromo-succinimide is 1:1.1-1.3.
Described method, catalyzer comprises zinc chloride, iron(ic) chloride, zirconium chloride or aluminum chloride.
Described method, in step a, the reaction times is 24-30 hour, in step b, the reaction times is 4-7 hour.
Described method, in step a, aftertreatment is cancellation, extraction, washing, concentrated, add organic solvent crystallization.
Described method, in step b, aftertreatment is water cancellation, is extracted with ethyl acetate, and through 3 washings, is concentrated into dryly, adds mixed solvent crystallization.
Described method, in step c, aftertreatment adds 5% sodium carbonate solution after being, separates organic layer, and water layer is extracted with ethyl acetate, and separates organic phase, through concentrated, adds mixed solvent crystallization.
Described method, in step a, described organic solvent is t-butyl methyl ether, methyl alcohol or ethanol.
In described method steps b, mixed solvent is that mol ratio is the t-butyl methyl ether of 2:4-6 and the solvent mixture of isohexane.
Described method, in step c, mixed solvent is that mol ratio is the t-butyl methyl ether of 2:2-3 and the solvent mixture of isohexane.
Beneficial effect: the inventive method adopts different reaction systems, comprises reaction raw materials, treatment processs etc., only obtain product by 3 step reactions, have effectively improved purity and the yield of product; Simple to operate, raw material is easy to get, and has saved running cost and material.
Embodiment
In order further to understand the present invention, below in conjunction with specific embodiment, the process of this programme is described, but should be appreciated that these are described is for further instruction the features and advantages of the present invention, rather than limiting to the claimed invention.
embodiment 1 5.5: 2: 1:1.1
A) room temperature adds 5.5mol aceticanhydride and 2mol zinc chloride, 10-15 ℃ minute 8 batches add 1mol semi-lactosi, after having reacted, add 1.1mol 2-mercaptobenzothiazole, be heated to 50-60 ℃; Through aftertreatment, obtain 0.87mol benzothiazolyl thioacetyl semi-lactosi.
B) 3.48mol potassium hydroxide and 0.87mol benzothiazolyl thioacetyl semi-lactosi are added in 8.7mol Benzyl Chloride and are heated to reflux, react rear cooling, pass through aftertreatment and obtain 0.79mol benzothiazolyl sulfo-tetrabenzyl semi-lactosi.
C) 0.79mol benzothiazolyl sulfo-tetrabenzyl semi-lactosi is added in 4mol acetone and is dissolved, add 2mol water, stir in room temperature and add 0.87mol N-bromo-succinimide, stir 0.5 hour, reacted through aftertreatment and obtained 0.71mol2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose, yield is 71%.
In step a, aftertreatment is stirred 2 hours for dripping the water of 0-5 ℃ of 10mol, and the ethyl acetate extraction aqueous layer extracted with 5mol, separates 10mol water washing organic phase for organic phase, separates organic phase concentrated, adds the crystallization of 1mol t-butyl methyl ether, filters, dry.
In step b, aftertreatment for to add 5mol water in reaction system, stir 30 minutes, ethyl acetate extraction aqueous layer extracted with 5mol, separate 5mol water washing organic phase for organic phase, wash three times, separate organic phase concentrated, be concentrated into dry, add the t-butyl methyl ether of 0.2mol and the crystallization of 0.4mol isohexane, filter, dry.
In step c, aftertreatment adds the sodium carbonate solution of 3mol 5% after being, separate organic layer, 3mol ethyl acetate extraction for water layer, separate organic phase, merge organic phase, with the water washing of 5mol, separate organic phase concentrated, add the t-butyl methyl ether of 0.2mol and the crystallization of 0.3mol isohexane, filter, dry
control Example
A) room temperature adds 6mol aceticanhydride and 2mol zinc chloride, 10-15 ℃ minute 8 batches add 1mol semi-lactosi, after having reacted, add 1.2mol toluene-ω-thiol, be heated to 50-60 ℃; Through aftertreatment, obtain 0.75mol p-methylphenyl thioacetyl semi-lactosi.
B) 3mol potassium hydroxide and 0.75mol p-methylphenyl thioacetyl semi-lactosi are added in 7.5mol Benzyl Chloride and are heated to reflux, react rear cooling, pass through aftertreatment and obtain 0.71mol p-methylphenyl sulfo-tetrabenzyl semi-lactosi.
C) 0.71mol p-methylphenyl sulfo-tetrabenzyl semi-lactosi is added in 4mol acetone and dissolves, add 2mol water, stir in room temperature and add 0.94mol N-bromo-succinimide, stir 0.5 hour, reacted through aftertreatment and obtained 0.62mol2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose, yield is 62%.

Claims (9)

1. one kind 2,3,4, the preparation method of 6-tetra--oxygen-benzyl-D-galactopyranose, is characterized in that comprising the following steps:
A) under room temperature, in reaction vessel, add aceticanhydride and catalyzer, 10-15 ℃ minute 8 batches add semi-lactosi, after having reacted, add 2-mercaptobenzothiazole, be heated to 50-60 ℃; Through aftertreatment, obtain benzothiazolyl thioacetyl semi-lactosi;
B) potassium hydroxide and benzothiazolyl thioacetyl semi-lactosi are added to and in Benzyl Chloride, are heated to back flow reaction and complete, reacted rear cooling, through aftertreatment, obtain benzothiazolyl sulfo-tetrabenzyl semi-lactosi;
C) benzothiazolyl sulfo-tetrabenzyl semi-lactosi is added in acetone and is dissolved, add water, stir in room temperature and add N-bromo-succinimide, stir 0.5 hour, reacted through aftertreatment and obtained 2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose;
Aceticanhydride in described step a: catalyzer: semi-lactosi: the mol ratio of 2-mercaptobenzothiazole is 5.5:2:1:1.1.
2. preparation method according to claim 1, is characterized in that benzothiazolyl thioacetyl semi-lactosi in step b: Benzyl Chloride: the mol ratio of potassium hydroxide is 1:10-15: 4-8.
3. preparation method according to claim 1, is characterized in that in step c, the mol ratio of benzothiazolyl sulfo-tetrabenzyl semi-lactosi and N-bromo-succinimide is 1:1.1-1.3.
4. preparation method according to claim 1, described method, catalyzer is more than one in zinc chloride, iron(ic) chloride, zirconium chloride and aluminum chloride.
5. preparation method according to claim 1, is characterized in that, in step a, the reaction times is 24-30 hour, and in step b, the reaction times is 4-7 hour.
6. preparation method according to claim 1, is characterized in that in step a, aftertreatment is cancellation, extraction, and washing, concentrated, add organic solvent crystallization.
7. preparation method according to claim 1, is characterized in that in step b, aftertreatment is water cancellation, is extracted with ethyl acetate, and through 3 washings, is concentrated into dryly, adds mixed solvent crystallization.
8. preparation method according to claim 1, is characterized in that aftertreatment in step c adds 5% sodium carbonate solution after being, separates organic layer, and water layer is extracted with ethyl acetate, and separates organic phase, through concentrated, adds mixed solvent crystallization.
9. preparation method according to claim 8, is characterized in that in step c, and mixed solvent is that mol ratio is the t-butyl methyl ether of 2:2-3 and the solvent mixture of isohexane.
CN201310671212.8A 2013-12-12 2013-12-12 The preparation method of 2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose Active CN103694290B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310671212.8A CN103694290B (en) 2013-12-12 2013-12-12 The preparation method of 2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310671212.8A CN103694290B (en) 2013-12-12 2013-12-12 The preparation method of 2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose

Publications (2)

Publication Number Publication Date
CN103694290A true CN103694290A (en) 2014-04-02
CN103694290B CN103694290B (en) 2016-08-17

Family

ID=50355975

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310671212.8A Active CN103694290B (en) 2013-12-12 2013-12-12 The preparation method of 2,3,4,6-tetra--oxygen-benzyl-D-galactopyranose

Country Status (1)

Country Link
CN (1) CN103694290B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1590394A (en) * 2003-09-01 2005-03-09 北京大学 New type trisaccharide and penta saccharid oligo saccharide antigen, their synthesis method and application in preparation of medicine for inhibiting exclusion reaction
CN1715286A (en) * 2004-07-02 2006-01-04 北京大学 Synthetic method for pentose antigen for inhibiting heterogenic organ transplant immune rejection reaction
CN101775051A (en) * 2010-01-07 2010-07-14 北京大学 Method for regioselectively removing O-benzyl protective group of sugar
US20130158242A1 (en) * 2011-12-16 2013-06-20 National Chiao Tung University Alpha-selective glycosylation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1590394A (en) * 2003-09-01 2005-03-09 北京大学 New type trisaccharide and penta saccharid oligo saccharide antigen, their synthesis method and application in preparation of medicine for inhibiting exclusion reaction
CN1715286A (en) * 2004-07-02 2006-01-04 北京大学 Synthetic method for pentose antigen for inhibiting heterogenic organ transplant immune rejection reaction
CN101775051A (en) * 2010-01-07 2010-07-14 北京大学 Method for regioselectively removing O-benzyl protective group of sugar
US20130158242A1 (en) * 2011-12-16 2013-06-20 National Chiao Tung University Alpha-selective glycosylation method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DANIELE PRO,等: "Impact of glycosylation on physicoechemical and biological properties of nitrification inhibitors", 《TETRAHEDRON》, vol. 68, 21 June 2012 (2012-06-21), XP028426172, DOI: doi:10.1016/j.tet.2012.06.060 *
XIN-SHAN YE,等: "Synthetic Iminosugar Derivatives as New Potential Immunosuppressive Agents", 《J. MED. CHEM.》, vol. 48, no. 11, 4 May 2005 (2005-05-04), pages 3688 - 3691 *
李翔,等: "N-(9-芴甲氧羰基)-O-(2,3,4,6-四苄基-α-D-半乳糖基)-L-丝氨酸的合成", 《第二军医大学学报》, vol. 32, no. 11, 30 November 2011 (2011-11-30) *

Also Published As

Publication number Publication date
CN103694290B (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN103910775A (en) Synthesis method of 17alpha-hydroxyl progesterone
CN105218610B (en) Method for synthesizing cholesterol by using stigmasterol degradation products as raw materials
CN102993246A (en) Method for synthesizing isopropyl-beta-D-thiogalactoside
CN110003298B (en) Synthetic method of promestrene
CN107602651A (en) A kind of preparation method of dehydroepiandros-sterone intermediate and dehydroepiandros-sterone
CN103709209A (en) Isopropyl-beta-D-thiogalactoside preparation method
CN103665064A (en) Method for preparing 2,3,4,6-tetra-O-benzyl -D-galactose
CN103665063B (en) A kind of method preparing isopropyl-β-D-thiogalactoside(IPTG)
CN103694288A (en) Method for preparing 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose
CN103694290A (en) Preparation method of 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose
CN103694289A (en) Preparation method of 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose
CN106046077A (en) Tulathromycin A synthesis method
CN103059096A (en) Synthesis method of deflazacort intermediate with [17a,16a-d] oxazoline structure
CN103694287A (en) Technique for preparing 2,3,4,6-tetra-oxy-benzyl-D-galactopyranose
CN103709210A (en) Isopropyl-beta-D-thiogalactoside preparation technology
CN102924346B (en) Method for synthesizing methyl sulfone base dibromo toluene
CN103709212A (en) Preparation technology of 2,3,4,6-tetra-oxo-benzyl-D-galactopyranose
CN103265586B (en) A kind of method being prepared Lauryl.beta.-maltoside by maltose
CN103387519B (en) Preparation method for 4-hydroxybenzyl cyanide
CN103694285B (en) A kind of preparation method of isopropyl-β-D-thiogalactoside(IPTG)
CN103694284B (en) A kind of preparation technology of isopropyl-β-D-thiogalactoside(IPTG)
CN103694286B (en) Prepare the method for isopropyl-β-D-thiogalactoside(IPTG)
CN106749463A (en) A kind of method that methyltestosterone is reclaimed in the mother liquor from methyltestosterone
CN103896784B (en) A kind of FTY720 intermediate nitroreduction is amino method
CN108129536A (en) A kind of preparation method of Dexamethasone Intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Shengquan Industrial Park 250204 Shandong city of Ji'nan province Zhangqiu City Diao Town Industrial Development Zone

Applicant after: CARBOTANG BIOTECH CO.,LTD.

Address before: Shengquan Industrial Park 250204 Shandong city of Ji'nan province Zhangqiu City Diao Town Industrial Development Zone

Applicant before: CARBOTANG LTD.

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 250204 Diaozhen Street Chemical Industrial Park, Zhangqiu District, Jinan City, Shandong Province

Patentee after: Jinan Carbotang Biotech Co.,Ltd.

Address before: 250204 Shengquan Industrial Park, Diaozhen Industrial Development Zone, Zhangqiu City, Jinan City, Shandong Province

Patentee before: CARBOTANG BIOTECH CO.,LTD.

CP03 Change of name, title or address